EU
Keytruda scores EU approval in combination with Inlyta for first-line advanced renal cell carcinoma
September 4, 2019Research and Development, Sales and Marketing EU, Europe, MSD, keytruda, pharma, renal cell carcinoma
The European Commission has awarded yet another authorisation in the region to MSD’s Keytruda, this time in combination with the …
British and American healthcare professionals predict further delays to Brexit as Europeans expect no-deal
August 19, 2019Sales and Marketing EU, UK, US, brexit, brexit delay, healthcare, no-deal, pharma
The majority of healthcare professionals in Europe, Britain and America think Brexit will happen. However they do not believe that …
EU unprepared for no-deal Brexit, health experts warn
August 12, 2019Sales and Marketing EU, Euroepan Union, UK, brexit, pharma
European health experts have warned that a no-deal Brexit could worsen medicines shortages in the European Union. Speaking to Reuters, …
Sanofi’s Dupixent extended in Europe to cover adolescents in atopic dermatitis
August 6, 2019Manufacturing and Production, Sales and Marketing EU, Europe, Sanofi, atopic dermatits, pharma
Sanofi has announced that European Commission (EC) has chosen to extend the marketing approval of its interleukin-4 (IL-4) and interleukin-13 …
Bayer’s Vitravki poised to become first tumour-agnostic therapy in EU following CHMP recommendation
July 30, 2019Manufacturing and Production, Sales and Marketing Bayer, CHMP, Cancer, EU, Vitrakvi, pharma
Bayer’s oral TRK inhibitor Vitrakvi (larotrectinib) could be set to become the European Union’s first drug approved in a tumour-agnostic …
No-deal Brexit could cause shortages and higher prices, healthcare distributors warn
June 19, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, distribution, pharma, supply chain
The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …
Contract manufacturing services industry set to grow at CAGR of 10.6% between 2017-2027
June 19, 2019Research and Development EU, Europe, biopharma, contract manufacturing services, manufacturing, pharma
The biopharmaceutical contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 10.6% between 2017 …
EU pharmaceutical industry lost €16.5 billion in sales as staff shift to patent infringing firms
June 19, 2019Research and Development EU, counterfeit, generics, pharma, sales
A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 …
Sanofi’s Dupixent approved in Europe for severe asthma maintenance
May 9, 2019Sales and Marketing Dupixent, EU, Europe, Sanofi, asthma, pharma
Sanofi has revealed that its interleukin-4 and interleukin-13 (IL-4 and IL-13) inhibitor Dupixent (dupilumab) has been awarded marketing approval by …
Teva’s Ajovy injection secures EU approval for the prevention of migraine
April 2, 2019Manufacturing and Production, Sales and Marketing EU, Europe, Teva, ajovy, migraine, pharma
Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (fremanezumab) has been awarded marketing authorisation by the European …
Sanofi may airlift flu vaccines into UK after Brexit
March 26, 2019Manufacturing and Production EU, France, Sanofi, UK, brexit, channel tunnel, vaccines
French firm Sanofi would airlift flu vaccines into the UK in the case of a highly disruptive exit from the …
Breast cancer mortality rates fall faster in Britain than elsewhere in Europe
March 19, 2019Manufacturing and Production, Research and Development Cancer, EU, Europe, France, Italy, Poland, UK, breast cancer, german, oncology
Death rates from breast cancer are falling faster in Britain than in any of the other six most populous countries …
Roche scores two EU approvals in haemophilia and rare autoimmune disease
March 15, 2019Medical Communications EC, EU, Europe, Roche, haemophilia, rare diseases
The European Commission (EC) has approved Roche’s haemophilia treatment Hemlibra (emicizumab). The approval comes as the EC approved Roche’s MabThera …
Rise in populism linked to vaccine hesitancy in Europe, study shows
February 26, 2019Manufacturing and Production EU, Europe, populism, populist parties, vaccine hesitancy, vaccines
Parent’s reluctance to vaccinate their children correlates with the number of people voting for populist parties, according to a study …
Latest content
Five Facts about cardiovascular disease
